| 1.7 |
5.0 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.3 |
6.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 1.2 |
8.6 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 1.1 |
3.2 |
GO:0097237 |
response to cobalt ion(GO:0032025) cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 1.1 |
3.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.9 |
3.7 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.7 |
3.7 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.7 |
2.2 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.7 |
2.8 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.6 |
1.8 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.6 |
2.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.6 |
1.7 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.5 |
1.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) positive regulation of sarcomere organization(GO:0060298) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 |
6.3 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.5 |
1.4 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.4 |
3.4 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.4 |
2.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.3 |
1.4 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.3 |
1.3 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.3 |
1.6 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 |
2.9 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.3 |
0.3 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 |
2.0 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.2 |
1.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.2 |
0.9 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.2 |
0.7 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.2 |
1.2 |
GO:0072205 |
collecting duct development(GO:0072044) metanephric tubule development(GO:0072170) metanephric collecting duct development(GO:0072205) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
| 0.2 |
0.8 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.2 |
0.4 |
GO:0045726 |
regulation of integrin biosynthetic process(GO:0045113) positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.2 |
2.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.2 |
3.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
0.7 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
1.3 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
| 0.2 |
0.7 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 |
0.7 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.2 |
1.0 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 |
2.5 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.2 |
3.5 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.2 |
0.6 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
1.1 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.2 |
2.9 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.7 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.4 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.4 |
GO:0060547 |
negative regulation of necrotic cell death(GO:0060547) |
| 0.1 |
0.8 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
0.5 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 0.1 |
1.2 |
GO:1902624 |
positive regulation of neutrophil chemotaxis(GO:0090023) positive regulation of neutrophil migration(GO:1902624) |
| 0.1 |
0.4 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.8 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.4 |
GO:0001907 |
cytolysis by symbiont of host cells(GO:0001897) killing by symbiont of host cells(GO:0001907) hemolysis by symbiont of host erythrocytes(GO:0019836) disruption by symbiont of host cell(GO:0044004) hemolysis in other organism(GO:0044179) positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) cytolysis in other organism(GO:0051715) cytolysis in other organism involved in symbiotic interaction(GO:0051801) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 |
1.0 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
2.7 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.7 |
GO:0000089 |
mitotic metaphase(GO:0000089) |
| 0.1 |
1.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
2.4 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.1 |
0.3 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.1 |
0.3 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.1 |
0.3 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
1.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.5 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
0.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 |
0.7 |
GO:0006069 |
ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
| 0.1 |
0.6 |
GO:0035058 |
positive regulation of neuroblast proliferation(GO:0002052) nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.3 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 |
0.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.3 |
GO:0030155 |
regulation of cell adhesion(GO:0030155) |
| 0.1 |
0.3 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.1 |
0.9 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.8 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.1 |
0.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.4 |
GO:0032933 |
SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
1.3 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 |
0.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
4.4 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.1 |
0.5 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 0.1 |
0.3 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 |
0.3 |
GO:0030147 |
obsolete natriuresis(GO:0030147) |
| 0.1 |
0.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.1 |
0.2 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.1 |
0.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.1 |
0.1 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 |
2.5 |
GO:0002286 |
T cell activation involved in immune response(GO:0002286) |
| 0.1 |
0.7 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.1 |
1.0 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
0.4 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.2 |
GO:0001807 |
response to protozoan(GO:0001562) type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.1 |
3.5 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
0.2 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 |
0.3 |
GO:0009128 |
AMP catabolic process(GO:0006196) purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.1 |
0.4 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
2.7 |
GO:0006695 |
cholesterol biosynthetic process(GO:0006695) |
| 0.1 |
0.2 |
GO:2000858 |
renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) positive regulation of NAD(P)H oxidase activity(GO:0033864) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.0 |
0.1 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 |
0.1 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.0 |
GO:0019627 |
urea metabolic process(GO:0019627) |
| 0.0 |
1.3 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.0 |
0.5 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
1.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.2 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.6 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
0.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.2 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.0 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.2 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
1.0 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
1.6 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.1 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.0 |
0.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.4 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
3.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 |
0.4 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.0 |
0.5 |
GO:0034453 |
microtubule nucleation(GO:0007020) microtubule anchoring(GO:0034453) |
| 0.0 |
0.6 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.5 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.4 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.8 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.9 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.2 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.6 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 |
1.0 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.0 |
0.6 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
1.0 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.1 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.1 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.0 |
0.4 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.0 |
0.1 |
GO:0071372 |
atrial septum development(GO:0003283) septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) atrial septum morphogenesis(GO:0060413) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.6 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.0 |
0.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0030320 |
cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.0 |
1.0 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.0 |
0.7 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.8 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.2 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.0 |
0.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
| 0.0 |
0.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 |
0.0 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.0 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
1.3 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.3 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 |
0.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.7 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.0 |
0.4 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.5 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.1 |
GO:0070528 |
protein kinase C signaling(GO:0070528) |
| 0.0 |
3.6 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.4 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.0 |
0.1 |
GO:0044340 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.0 |
8.7 |
GO:0016337 |
single organismal cell-cell adhesion(GO:0016337) |
| 0.0 |
0.1 |
GO:0045822 |
negative regulation of heart contraction(GO:0045822) |
| 0.0 |
1.0 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.1 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.0 |
0.1 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.0 |
2.5 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.3 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.0 |
0.4 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.2 |
GO:0055070 |
cellular copper ion homeostasis(GO:0006878) COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) copper ion homeostasis(GO:0055070) |
| 0.0 |
0.1 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.0 |
0.1 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.0 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.0 |
0.2 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.2 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
7.4 |
GO:0007599 |
hemostasis(GO:0007599) |
| 0.0 |
2.4 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.1 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.0 |
0.6 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.0 |
GO:0060122 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.1 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
1.7 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
1.0 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.1 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 |
0.6 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.0 |
0.1 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
7.1 |
GO:0055085 |
transmembrane transport(GO:0055085) |
| 0.0 |
0.1 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.1 |
GO:0007569 |
cell aging(GO:0007569) |
